$EROK

EagleRock Announces Second Quarter 2026 Results

EagleRock Land, LLC (EROK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 EagleRock Announces Second Quarter 2026 Results August 10, 2026 Delivers strong second quarter results surpassing company expectations Initiates full-year 2026 financial guidance above company forecast HOUSTON—(BUSINESS WIRE) —EagleRock Land, LLC (“EagleRock” or the

Original reporting
Published Aug 11, 2026, 1:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EROK
Bullish
medium confidence
Mentioned
$EROK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EROKBullishHigh
01

Why it matters

Q2 results show strong sequential growth in normalized revenue and Adjusted EBITDA, and the company raises full-year 2026 EBITDA expectations. It also announces an acquisition of Intrepid Ranch for $78.2M, expanding contiguous Delaware Basin acreage and fee/royalty monetization opportunities.

02

Market read

This is a combined earnings and guidance update plus a fresh M&A catalyst, which can reprice EROK’s forward EBITDA expectations and execution risk.

03

What to watch

Surface use royalties surged on a quarter basis, so traders may scrutinize sustainability of produced water takeaway/recycled water volumes and the pace of renegotiating/modernizing surface agreements post-acquisition.

Relevance 7/10Novelty 9/10Timing: filed pre-market/early trading today (Aug 10 filing, Aug 11 published) with Q2 results and full-year guidance

Background

EagleRock is a Permian-focused land operator that went public May 15, 2026, and reports results using normalized non-GAAP measures recast for post-IPO comparability.

Company-level read

Ticker impact

$EROKBullishMedium confidence
Context

EagleRock reports Q2 2026 normalized revenue of $46.8M, normalized Adjusted EBITDA of $36.2M, and initiates full-year 2026 guidance above forecast.

Expected impact

Likely positive bias for the next session and into guidance digestion, with upside sensitivity to further execution on EBITDA conversion and M&A integration.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: Q2 operating metrics, a full-year EBITDA range ($129M to $133M) above internal forecast, and a newly announced acquisition (Intrepid Ranch) expanding contiguous Delaware Basin exposure.

Market effects

Reinforces investor appetite for Permian royalty and fee-driven models with water and surface-use monetization, potentially supporting sentiment for similar land operators.

Highlights continued capital deployment in the Delaware Basin (Lea County, NM), which can marginally improve perceived activity and infrastructure buildout in the region.

Limited direct global linkage; primarily a US Permian micro-theme around water/surface monetization and consolidation.

Counterpoint

Normalized metrics are emphasized while GAAP shows a net loss; investors may discount the quality of earnings if cash flow conversion or interest burden reappears.

Key entities

  • EagleRock Land, LLC

    NYSE-listed land operator reporting Q2 2026 results, initiating full-year 2026 guidance, and announcing the Intrepid Ranch acquisition.

  • Intrepid Ranch

    Approximately 50,000-acre, 22,000-fee-acre position in Lea County, New Mexico acquired for $78.2M.

Related articles

$EROKHigh

EagleRock (EROK) Shares Fall 5% After JPMorgan Lowers Q3 EBITDA

EagleRock Land (EROK) shares fell 5% after JPMorgan reduced its Q3 EBITDA forecast to $28M, below consensus of $35M, citing seasonal declines in recycled water volumes. The stock closed at $20.56. JPMorgan maintains an Overweight rating with a lowered price target of $27. EagleRock operates in land management and water infrastructure in the Permian Basin.

$EROKMed

EagleRock Announces Filing of Quarterly Report on Form 10-Q

EagleRock Land, LLC (EROK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d295987dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE EagleRock Announces Filing of Quarterly Report on Form 10-Q HOUSTON, June 23, 2026 – EagleRock Land, LLC (“EagleRock” or the “Company”) (NYSE: EROK) today filed its Quarterly Report on Form 10-Q for the quarter

$NECBMed

NORTHEAST COMMUNITY BANCORP, INC. REPORTS RESULTS

NorthEast Community Bancorp, Inc./MD/ (NECB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NECB Earnings Press Release for 09/30/2026: NORTHEAST COMMUNITY BANCORP, INC. REPORTS RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 White Plains, New York, October 22, 2026 – NorthEast Community Bancorp, Inc. (Nasdaq: NECB) (the “Company”), the paren

$UNPHighAI 8/10

UBS reiterates Union Pacific stock rating on strong volume growth

UBS maintained a Buy rating and $339 price target for Union Pacific (UNP) after its Q3 earnings beat estimates, driven by 6% volume growth and 9% revenue increase. The stock is up 31% YTD. Analysts cite strong financials, including a perfect Piotroski Score and 19 years of dividend growth. Other firms also raised targets, noting volume growth and merger progress.

$CACIMedAI 8/10

UBS lowers CACI International stock price target on valuation

UBS lowered its price target on CACI International (NYSE:CACI) to $823 from $826, maintaining a Buy rating. The defense contractor expects strong organic growth and margin expansion. CACI reported Q1 fiscal 2027 EPS of $7.66, beating estimates, but revenue was slightly below expectations. Stifel raised its price target to $925 from $892, citing strong margin performance.

$ABTMed

StoneX reiterates Buy on Abbott Labs stock, $120 target unchanged

StoneX reiterated a Buy rating and $120 target for Abbott Labs (ABT) after Q3 results. Abbott lowered its full-year revenue guidance to 6% and adjusted EPS to $5.50-$5.55. StoneX reduced its 2026 and 2027 revenue and EPS estimates. Abbott's Q3 revenue was $13.01B, up 7%, with adjusted EPS of $1.42. The company plans to spin off its Nutrition business by 2027. Analysts have mixed reactions to the guidance changes.